July 6, 2026 · Form 4 insider transaction
Jones Mitchell Lawrence bought 131,167 shares of Palisade Bio, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs") granted on February 9, 2026.; Includes 1,459 shares acquired under the Issuer's Employee Stock Purchase Plan on May 20, 2026.